Medera, Inc., (“Medera”), a clinical-stage biotechnology company, announced today that the management team will participate ...
Plus Moritz Seider’s easing burden in Detroit, home-ice disadvantage in Utah, how multiple teams have adjusted amidst ...
HighlightsWell-mineralized channel intervals at the HW3 Pegmatite1.4 m at 6.00% Cs2O including 0.5 m at 12.40% Cs2O ...